Yield10 Bioscience, Inc. Common Stock
YTEN
YTEN was delisted on the 15th of May, 2024.
10 hedge funds and large institutions have $1.19M invested in Yield10 Bioscience, Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 3 reducing their positions, and 4 closing their positions.
18% more capital invested
Capital invested by funds: $1.01M → $1.19M (+$179K)
17% less funds holding
Funds holding: 12 → 10 (-2)
50% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 4
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
+$44.5K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
+$3.24K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$82.4K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$40K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$30.9K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$15.1K |
| 5 |
CWP
Concord Wealth Partners
Abingdon,
Virginia
|
-$8K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CC
1
Cannell & Co
New York
| $482K | -$270 | -4 | -0.1% |
|
|
2
Vanguard Group
Malvern,
Pennsylvania
| $309K | -$30.9K | -458 | -10% |
|
3
Geode Capital Management
Boston,
Massachusetts
| $105K | – | – | – |
|
4
BlackRock
New York
| $94K | – | – | – |
|
|
5
Millennium Management
New York
| $88K | -$82.4K | -1,221 | -50% |
|
|
BC
6
Birchview Capital
Burlington,
Vermont
| $56K | – | – | – |
|
|
VF
7
Virtu Financial
New York
| $47K | +$44.5K | +659 | New |
|
|
TRCT
8
Tower Research Capital (TRC)
New York
| $3K | +$3.24K | +48 | New |
|
|
IA
9
IFP Advisors
Tampa,
Florida
| $1K | – | – | – |
|
|
10
Citadel Advisors
Miami,
Florida
| – | -$40K | -745 | Closed |
|
|
11
UBS Group
Zurich,
Switzerland
| – | -$15.1K | -223 | Closed |
|
|
CWP
12
Concord Wealth Partners
Abingdon,
Virginia
| – | -$8K | -146 | Closed |
|
|
RMC
13
Resources Management Corp
West Hartford,
Connecticut
| – | -$1K | -10 | Closed |
|
YTEN Hedge Fund Activity: Q3 2022 in Review
10 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Yield10 Bioscience, Inc. Common Stock (YTEN) for Q3 2022, worth a combined $1.19M — up 18% from $1.01M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of YTEN and 2 opened new positions — a net loss of 2 holders — while 3 trimmed existing stakes and 0 added.
The largest buyer was Virtu Financial, opening a new position worth an estimated $44.5K. The largest seller was Millennium Management, cutting an estimated $82.4K.
- 10 institutional investors held Yield10 Bioscience, Inc. Common Stock (YTEN) as of Q3 2022, down from 12 in Q2 2022.
- Funds reported $1.19M of Yield10 Bioscience, Inc. Common Stock stock for Q3 2022, up 18% quarter-over-quarter.
- 2 funds opened new Yield10 Bioscience, Inc. Common Stock positions in Q3 2022 and 4 closed out, a net change of -2 holders.
- The largest Yield10 Bioscience, Inc. Common Stock buyer in Q3 2022 was Virtu Financial, an estimated $44.5K added.
- The largest Yield10 Bioscience, Inc. Common Stock seller in Q3 2022 was Millennium Management, an estimated $82.4K sold.
Based on aggregated 13F filings for Q3 2022.